Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

On 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health ...

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

Without explicitly naming the alternative — Novavax — the Sept. 12 guidance appeared to reluctantly endorse that vaccine for ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

Novavax confirmed that the above clinical hold does not impact its current COVID-19 vaccine. The clinical hold announcement did not sit well with the investors, who cited worries over Novavax’s ...

Gaithersburg-based Novavax Inc. (NASDAQ ... have put the brakes on a phase 3 study for two key vaccine candidates: one for both Covid-19 and seasonal flu, and another for just influenza.

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

The company in May had signed a deal worth at least $1.2 billion with Sanofi to co-sell Novavax’s vaccine in most countries and use the COVID shot along with its own flu vaccines to develop a ...

Novavax: The Novavax was the fourth COVID vaccine to be administered in the U.S., after Johnson & Johnson, which is no longer available. The Novavax vaccine is the only non-mRNA updated COVID ...